1	Angiogenesis-a	Angiogenesis-a	B-NP	JJ	O	3	AMOD	3	Angiogenesis
2	novel	novel	I-NP	JJ	O	3	AMOD	-1
3	therapeutic	therapeutic	I-NP	JJ	O	4	NMOD	-1
4	approach	approach	I-NP	NN	O	0	ROOT	-1
5	for	for	B-PP	IN	O	4	NMOD	-1
6	ischemic	ischemic	B-NP	JJ	O	8	NMOD	-1
7	heart	heart	I-NP	NN	O	8	NMOD	-1
8	disease	disease	I-NP	NN	O	5	PMOD	-1
9	.	.	O	.	O	4	P	-1

1	Angiogenesis	Angiogenesis	B-NP	NN	O	2	SUB	3	Angiogenesis
2	is	be	B-VP	VBZ	O	0	ROOT	-1
3	the	the	B-NP	DT	O	5	NMOD	-1
4	biologic	biologic	I-NP	JJ	O	5	NMOD	-1
5	process	process	I-NP	NN	O	2	PRD	-1
6	of	of	B-PP	IN	O	5	NMOD	-1
7	forming	form	B-VP	VBG	O	6	PMOD	2	forming
8	new	new	B-NP	JJ	O	10	NMOD	-1
9	blood	blood	I-NP	NN	O	10	NMOD	-1
10	vessels	vessel	I-NP	NNS	O	7	OBJ	-1
11	.	.	O	.	O	2	P	-1

1	Undoubtedly	Undoubtedly	B-ADVP	RB	O	7	VMOD	-1
2	,	,	O	,	O	7	P	-1
3	blood	blood	B-NP	NN	O	4	NMOD	-1
4	vessels	vessel	I-NP	NNS	O	6	NMOD	-1
5	growth	growth	I-NP	NN	O	6	NMOD	4	growth
6	regulation	regulation	I-NP	NN	O	7	SUB	16	regulation
7	is	be	B-VP	VBZ	O	0	ROOT	-1
8	a	a	B-NP	DT	O	10	NMOD	-1
9	vital	vital	I-NP	JJ	O	10	NMOD	-1
10	aspect	aspect	I-NP	NN	O	7	PRD	-1
11	in	in	B-PP	IN	O	10	NMOD	-1
12	health	health	B-NP	NN	O	14	NMOD	-1
13	and	and	I-NP	CC	O	14	NMOD	-1
14	disease	disease	I-NP	NN	O	11	PMOD	-1
15	.	.	O	.	O	7	P	-1

1	Under	Under	B-PP	IN	O	6	VMOD	-1
2	physiological	physiological	B-NP	JJ	O	3	NMOD	-1
3	conditions	condition	I-NP	NNS	O	1	PMOD	-1
4	,	,	O	,	O	6	P	-1
5	angiogenesis	angiogenesis	B-NP	NN	O	6	SUB	3	angiogenesis
6	is	be	B-VP	VBZ	O	0	ROOT	-1
7	regulated	regulate	I-VP	VBN	O	6	VC	16	regulated
8	by	by	B-PP	IN	O	7	VMOD	-1
9	local	local	B-NP	JJ	O	10	NMOD	-1
10	balance	balance	I-NP	NN	O	8	PMOD	-1
11	between	between	B-PP	IN	O	10	NMOD	-1
12	endogenous	endogenous	B-NP	JJ	O	13	NMOD	-1
13	stimulators	stimulator	I-NP	NNS	O	15	NMOD	-1
14	and	and	I-NP	CC	O	15	NMOD	-1
15	inhibitors	inhibitor	I-NP	NNS	O	11	PMOD	-1
16	of	of	B-PP	IN	O	15	NMOD	-1
17	this	this	B-NP	DT	O	18	NMOD	-1
18	process	process	I-NP	NN	O	16	PMOD	-1
19	.	.	O	.	O	6	P	-1

1	In	In	B-PP	IN	O	6	VMOD	-1
2	many	many	B-NP	JJ	O	3	NMOD	-1
3	diseases	disease	I-NP	NNS	O	1	PMOD	-1
4	state	state	I-NP	NN	O	1	PMOD	-1
5	body	body	I-NP	NN	O	6	SUB	-1
6	loses	lose	B-VP	VBZ	O	0	ROOT	-1
7	control	control	B-NP	NN	O	6	OBJ	16	control
8	over	over	B-PP	IN	O	6	VMOD	-1
9	angiogenesis	angiogenesis	B-NP	NN	O	8	PMOD	3	angiogenesis
10	.	.	O	.	O	6	P	-1

1	Angiogenesis-dependent	Angiogenesis-dependent	B-NP	JJ	O	2	NMOD	3	Angiogenesis
2	diseases	disease	I-NP	NNS	O	3	SUB	-1
3	result	result	B-VP	VBP	O	0	ROOT	-1
4	when	when	B-ADVP	WRB	O	3	VMOD	-1
5	new	new	B-NP	JJ	O	7	NMOD	-1
6	blood	blood	I-NP	NN	O	7	NMOD	-1
7	vessels	vessel	I-NP	NNS	O	9	SUB	-1
8	either	either	O	CC	O	9	VMOD	-1
9	grow	grow	B-VP	VB	O	4	SBAR	4	grow
10	excessively	excessively	B-ADVP	RB	O	9	VMOD	-1
11	or	or	I-ADVP	CC	O	10	AMOD	-1
12	insufficiently	insufficiently	I-ADVP	RB	O	10	AMOD	-1
13	.	.	O	.	O	3	P	-1

1	Insufficient	Insufficient	B-NP	JJ	O	2	NMOD	-1
2	angiogenesis	angiogenesis	I-NP	NN	O	3	SUB	3	angiogenesis
3	occurs	occur	B-VP	VBZ	O	0	ROOT	-1
4	in	in	B-PP	IN	O	3	VMOD	-1
5	diseases	disease	B-NP	NNS	O	4	PMOD	-1
6	such	such	B-PP	JJ	O	7	PMOD	-1
7	as	as	I-PP	IN	O	5	NMOD	-1
8	coronary	coronary	B-NP	JJ	O	10	NMOD	-1
9	artery	artery	I-NP	NN	O	10	NMOD	-1
10	disease	disease	I-NP	NN	O	15	NMOD	-1
11	,	,	O	,	O	15	P	-1
12	stroke	stroke	B-NP	NN	O	15	NMOD	-1
13	and	and	O	CC	O	15	NMOD	-1
14	chronic	chronic	B-NP	JJ	O	15	NMOD	-1
15	wounds	wound	I-NP	NNS	O	7	PMOD	-1
16	.	.	O	.	O	3	P	-1

1	Myocardial	Myocardial	B-NP	JJ	O	2	NMOD	-1
2	ischemia	ischemia	I-NP	NN	O	7	SUB	-1
3	both	both	O	CC	O	6	AMOD	-1
4	acute	acute	B-ADJP	JJ	O	6	AMOD	-1
5	and	and	I-ADJP	CC	O	6	AMOD	-1
6	chronic	chronic	I-ADJP	JJ	O	2	NMOD	-1
7	has	have	B-VP	VBZ	O	0	ROOT	-1
8	been	be	I-VP	VBN	O	7	VC	-1
9	clearly	clearly	I-VP	RB	O	8	VMOD	-1
10	shown	show	I-VP	VBN	O	8	VC	-1
11	to	to	I-VP	TO	O	12	VMOD	-1
12	stimulate	stimulate	I-VP	VB	O	10	VMOD	17	stimulate
13	angiogenesis	angiogenesis	B-NP	NN	O	12	OBJ	3	angiogenesis
14	in	in	B-PP	IN	O	12	VMOD	-1
15	many	many	B-NP	JJ	O	17	NMOD	-1
16	experimental	experimental	I-NP	JJ	O	17	NMOD	-1
17	models	model	I-NP	NNS	O	14	PMOD	-1
18	.	.	O	.	O	7	P	-1

1	Therapeutic	Therapeutic	B-NP	JJ	O	2	NMOD	-1
2	angiogenesis	angiogenesis	I-NP	NN	O	3	SUB	3	angiogenesis
3	is	be	B-VP	VBZ	O	0	ROOT	-1
4	the	the	B-NP	DT	O	6	NMOD	-1
5	biological	biological	I-NP	JJ	O	6	NMOD	-1
6	agents	agent	I-NP	NNS	O	9	NMOD	-1
7	or	or	O	CC	O	9	NMOD	-1
8	bioactive	bioactive	B-NP	JJ	O	9	NMOD	-1
9	material	material	I-NP	NN	O	3	PRD	-1
10	to	to	B-VP	TO	O	11	VMOD	-1
11	stimulate	stimulate	I-VP	VB	O	9	NMOD	17	stimulate
12	the	the	B-NP	DT	O	13	NMOD	-1
13	growth	growth	I-NP	NN	O	11	OBJ	4	growth
14	of	of	B-PP	IN	O	13	NMOD	-1
15	new	new	B-NP	JJ	O	17	NMOD	-1
16	blood	blood	I-NP	NN	O	17	NMOD	-1
17	vessels	vessel	I-NP	NNS	O	14	PMOD	-1
18	.	.	O	.	O	3	P	-1

1	Traditional	Traditional	B-NP	JJ	O	4	NMOD	-1
2	coronary	coronary	I-NP	JJ	O	4	NMOD	-1
3	revascularization	revascularization	I-NP	NN	O	4	NMOD	3	revascularization
4	therapies	therapy	I-NP	NNS	O	14	SUB	0
5	such	such	B-PP	JJ	O	6	PMOD	-1
6	as	as	I-PP	IN	O	4	NMOD	-1
7	coronary	coronary	B-NP	JJ	O	8	AMOD	-1
8	angioplasty	angioplasty	I-NP	JJ	O	12	NMOD	-1
9	or	or	I-NP	CC	O	12	NMOD	-1
10	bypass	bypass	I-NP	JJ	O	12	NMOD	-1
11	graft	graft	I-NP	NN	O	12	NMOD	-1
12	surgery	surgery	I-NP	NN	O	6	PMOD	0
13	,	,	O	,	O	4	P	-1
14	act	act	B-VP	VBP	O	0	ROOT	0
15	by	by	B-PP	IN	O	14	VMOD	-1
16	restoring	restore	B-VP	VBG	O	15	PMOD	16	restoring
17	blood	blood	B-NP	NN	O	18	NMOD	-1
18	flow	flow	I-NP	NN	O	16	OBJ	-1
19	through	through	B-PP	IN	O	16	VMOD	0
20	the	the	B-NP	DT	O	23	NMOD	-1
21	preexisting	preexisting	I-NP	JJ	O	23	NMOD	14	preexisting
22	coronary	coronary	I-NP	JJ	O	23	NMOD	-1
23	vessels	vessel	I-NP	NNS	O	19	PMOD	-1
24	.	.	O	.	O	14	P	-1

1	One	One	B-NP	CD	O	2	NMOD	-1
2	limitation	limitation	I-NP	NN	O	9	SUB	-1
3	of	of	B-PP	IN	O	2	NMOD	-1
4	these	these	B-NP	DT	O	5	NMOD	-1
5	approaches	approach	I-NP	NNS	O	3	PMOD	-1
6	,	,	O	,	O	9	P	-1
7	however	however	B-ADVP	RB	O	9	VMOD	-1
8	,	,	O	,	O	9	P	-1
9	may	may	B-VP	MD	O	0	ROOT	-1
10	be	be	I-VP	VB	O	9	VC	-1
11	the	the	B-NP	DT	O	12	NMOD	-1
12	failure	failure	I-NP	NN	O	10	PRD	-1
13	to	to	B-VP	TO	O	14	VMOD	-1
14	normalize	normalize	I-VP	VB	O	12	NMOD	-1
15	myocardial	myocardial	B-NP	JJ	O	16	NMOD	-1
16	perfusion	perfusion	I-NP	NN	O	14	OBJ	0
17	,	,	O	,	O	10	P	-1
18	due	due	B-PP	IN	O	19	PMOD	0
19	to	to	B-PP	TO	O	10	PRD	-1
20	the	the	B-NP	DT	O	22	NMOD	-1
21	concomitant	concomitant	I-NP	JJ	O	22	NMOD	-1
22	presence	presence	I-NP	NN	O	19	PMOD	0
23	or	or	O	CC	O	22	NMOD	-1
24	small	small	B-ADJP	JJ	O	23	PRD	-1
25	of	of	B-PP	IN	O	24	AMOD	-1
26	resistance	resistance	B-NP	NN	O	28	NMOD	-1
27	vessel	vessel	I-NP	NN	O	28	NMOD	-1
28	disease	disease	I-NP	NN	O	25	PMOD	-1
29	.	.	O	.	O	9	P	-1

1	In	In	B-PP	IN	O	6	VMOD	-1
2	contrast	contrast	B-NP	NN	O	1	PMOD	-1
3	,	,	O	,	O	6	P	-1
4	therapeutic	therapeutic	B-NP	JJ	O	5	NMOD	-1
5	angiogenesis	angiogenesis	I-NP	NN	O	6	SUB	3	angiogenesis
6	is	be	B-VP	VBZ	O	0	ROOT	-1
7	based	base	I-VP	VBN	O	6	VC	-1
8	on	on	B-PP	IN	O	7	VMOD	-1
9	the	the	B-NP	DT	O	10	NMOD	-1
10	concept	concept	I-NP	NN	O	8	PMOD	-1
11	that	that	B-SBAR	IN	O	10	NMOD	-1
12	coronary	coronary	B-NP	JJ	O	14	NMOD	-1
13	collateral	collateral	I-NP	JJ	O	14	NMOD	-1
14	development	development	I-NP	NN	O	15	SUB	2	development
15	may	may	B-VP	MD	O	11	SBAR	-1
16	be	be	I-VP	VB	O	15	VC	-1
17	stimulated	stimulate	I-VP	VBN	O	16	VC	17	stimulated
18	by	by	B-PP	IN	O	17	VMOD	-1
19	pharmacological	pharmacological	B-NP	JJ	O	21	AMOD	-1
20	or	or	I-NP	CC	O	21	AMOD	-1
21	molecular	molecular	I-NP	JJ	O	22	NMOD	-1
22	means	mean	I-NP	NNS	O	18	PMOD	-1
23	and	and	O	CC	O	6	VMOD	-1
24	can	can	B-VP	MD	O	6	VMOD	-1
25	limit	limit	I-VP	VB	O	24	VC	0
26	myocardial	myocardial	B-NP	JJ	O	27	NMOD	-1
27	ischemia	ischemia	I-NP	NN	O	25	OBJ	-1
28	.	.	O	.	O	6	P	-1

1	Studies	Study	B-NP	NNS	O	9	SUB	-1
2	,	,	O	,	O	9	P	-1
3	both	both	O	CC	O	9	VMOD	-1
4	in	in	B-PP	IN	O	9	VMOD	-1
5	human	human	B-NP	JJ	O	8	NMOD	-1
6	and	and	I-NP	CC	O	8	NMOD	-1
7	animal	animal	I-NP	JJ	O	8	NMOD	-1
8	models	model	I-NP	NNS	O	4	PMOD	-1
9	support	support	B-VP	VBP	O	0	ROOT	0
10	the	the	B-NP	DT	O	11	NMOD	-1
11	notion	notion	I-NP	NN	O	9	OBJ	-1
12	that	that	B-SBAR	IN	O	11	NMOD	-1
13	,	,	O	,	O	21	P	-1
14	various	various	B-NP	JJ	O	21	SUB	-1
15	angiogenic	angiogenic	I-NP	JJ	B-protein	17	NMOD	3	angiogenic
16	growth	growth	I-NP	NN	I-protein	17	NMOD	0
17	factors	factor	I-NP	NNS	I-protein	14	NMOD	-1
18	and	and	O	CC	O	20	NMOD	-1
19	progenitor	progenitor	B-NP	NN	B-cell_type	20	NMOD	-1
20	cells	cell	I-NP	NNS	I-cell_type	14	NMOD	-1
21	can	can	B-VP	MD	O	12	SBAR	-1
22	enhance	enhance	I-VP	VB	O	21	VC	17	enhance
23	new	new	B-NP	JJ	O	25	NMOD	-1
24	blood	blood	I-NP	NN	O	25	NMOD	-1
25	vessels	vessel	I-NP	NNS	O	22	OBJ	-1
26	.	.	O	.	O	9	P	-1

1	Vascular	Vascular	B-NP	JJ	B-protein	4	NMOD	-1
2	endothelial	endothelial	I-NP	JJ	I-protein	4	NMOD	-1
3	growth	growth	I-NP	NN	I-protein	4	NMOD	0
4	factor	factor	I-NP	NN	I-protein	11	NMOD	-1
5	(	(	O	(	O	7	DEP	-1
6	VEGF	VEGF	B-NP	NN	B-protein	7	DEP	-1
7	)	)	O	)	O	4	NMOD	-1
8	,	,	O	,	O	11	P	-1
9	fibroblast	fibroblast	B-NP	NN	B-protein	11	NMOD	-1
10	growth	growth	I-NP	NN	I-protein	11	NMOD	0
11	factor	factor	I-NP	NN	I-protein	22	NMOD	-1
12	(	(	O	(	O	14	DEP	-1
13	FGF	FGF	B-NP	NN	B-protein	14	DEP	-1
14	)	)	O	)	O	11	NMOD	-1
15	,	,	O	,	O	22	P	-1
16	recombinant	recombinant	B-NP	JJ	B-protein	17	NMOD	-1
17	proteins	protein	I-NP	NNS	I-protein	22	NMOD	-1
18	and	and	O	CC	O	22	NMOD	-1
19	bone	bone	B-NP	NN	B-cell_type	22	NMOD	-1
20	marrow	marrow	I-NP	NN	I-cell_type	22	NMOD	-1
21	stem	stem	I-NP	NN	I-cell_type	22	NMOD	-1
22	cells	cell	I-NP	NNS	I-cell_type	23	SUB	-1
23	are	be	B-VP	VBP	O	0	ROOT	-1
24	currently	currently	I-VP	RB	O	23	VMOD	-1
25	used	use	I-VP	VBN	O	23	VC	0
26	therapeutic	therapeutic	B-NP	JJ	O	27	NMOD	-1
27	stimulators	stimulator	I-NP	NNS	O	25	OBJ	-1
28	for	for	B-PP	IN	O	27	NMOD	-1
29	angiogenesis	angiogenesis	B-NP	NN	O	28	PMOD	3	angiogenesis
30	.	.	O	.	O	23	P	-1

1	As	As	B-SBAR	IN	O	28	VMOD	-1
2	coronary	coronary	B-NP	JJ	O	4	NMOD	-1
3	artery	artery	I-NP	NN	O	4	NMOD	-1
4	disease	disease	I-NP	NN	O	5	SUB	-1
5	is	be	B-VP	VBZ	O	1	SBAR	-1
6	the	the	B-NP	DT	O	8	NMOD	-1
7	major	major	I-NP	JJ	O	8	NMOD	-1
8	cause	cause	I-NP	NN	O	20	NMOD	-1
9	of	of	B-PP	IN	O	8	NMOD	-1
10	death	death	B-NP	NN	O	9	PMOD	0
11	in	in	B-PP	IN	O	8	NMOD	-1
12	the	the	B-NP	DT	O	14	NMOD	-1
13	developed	develop	I-NP	VBN	O	14	NMOD	0
14	societies	society	I-NP	NNS	O	11	PMOD	-1
15	and	and	O	CC	O	20	NMOD	-1
16	also	also	B-ADVP	RB	O	20	NMOD	-1
17	an	an	B-NP	DT	O	20	NMOD	-1
18	emerging	emerge	I-NP	VBG	O	20	NMOD	-1
19	health	health	I-NP	NN	O	20	NMOD	-1
20	problem	problem	I-NP	NN	O	5	PRD	-1
21	in	in	B-PP	IN	O	20	NMOD	-1
22	developing	develop	B-NP	VBG	O	23	NMOD	0
23	countries	country	I-NP	NNS	O	21	PMOD	-1
24	like	like	B-PP	IN	O	23	NMOD	-1
25	Bangladesh	Bangladesh	B-NP	NNP	O	27	NMOD	-1
26	therapeutic	therapeutic	I-NP	JJ	O	27	NMOD	-1
27	angiogenesis	angiogenesis	I-NP	NN	O	24	PMOD	3	angiogenesis
28	may	may	B-VP	MD	O	0	ROOT	-1
29	provide	provide	I-VP	VB	O	28	VC	-1
30	hope	hope	B-NP	NN	O	29	OBJ	-1
31	as	as	B-PP	IN	O	29	VMOD	-1
32	a	a	B-NP	DT	O	35	NMOD	-1
33	new	new	I-NP	JJ	O	35	NMOD	-1
34	treatment	treatment	I-NP	NN	O	35	NMOD	0
35	modality	modality	I-NP	NN	O	31	PMOD	-1
36	for	for	B-PP	IN	O	35	NMOD	-1
37	ischemic	ischemic	B-NP	JJ	O	39	NMOD	-1
38	heart	heart	I-NP	NN	O	39	NMOD	-1
39	disease	disease	I-NP	NN	O	36	PMOD	-1
40	with	with	B-PP	IN	O	39	NMOD	-1
41	or	or	B-PP	CC	O	40	PMOD	-1
42	in	in	B-PP	IN	O	40	PMOD	-1
43	place	place	B-NP	NN	O	42	PMOD	-1
44	of	of	B-PP	IN	O	43	NMOD	-1
45	current	current	B-NP	JJ	O	46	NMOD	-1
46	therapies	therapy	I-NP	NNS	O	44	PMOD	0
